Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects with Tenosynovial Giant Cell Tumour
Study Type: Treatment
Phase: III
NCTID: NCT05417789
Principal Investigator:
Benjamin Powers
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas PAZNTIS: A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minues Pazopanib NSC 737754, IND 118613
Study Type: Treatment
Phase: II/III
NCTID: NCT02180867
Principal Investigator:
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
Study Type: Other
Phase: N/A
NCTID: NCT03206450
Principal Investigator:
Keith August
A Phase 2, Multicenter, Open-label Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects With Relapsed/Refractory Rhabdomyosarcoma RMS, Non-rhabdomyosarcoma Soft Tissue Sarcoma NRSTS and Ewing Sarcoma EWS
Study Type: Treatment
Phase: II
NCTID: NCT03441360
Principal Investigator:
Kevin Ginn
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide VAC Alternating with Vincristine and Irinotecan VI versus VAC/VI plus Temsirolimus TORI, Torisel, NSC 683864 in Patients with Intermediate Risk IR Rhabdomyosarcoma RMS
Study Type: Treatment
Phase: III
NCTID: NCT02567435
Principal Investigator:
Keith August
Phase II Trial of XL184 Cabozantinib an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
Study Type: Treatment
Phase: II
NCTID: NCT02867592
Principal Investigator:
Kevin Ginn
Single Person IND for the Use of TK216 in a patient with metastatic Ewing sarcoma
Study Type: Treatment
Phase: N/A
NCTID: NCT00000000
Principal Investigator:
Benjamin Powers
Randomized Phase II Trial Evaluation the Addition of the IGF-1R Monoclonal Antibody Receptor Ganitumab to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
Study Type: Treatment
Phase: II
NCTID: NCT02306161
Principal Investigator:
A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity
Study Type: Treatment
Phase: II
NCTID: NCT03092323
Principal Investigator:
Benjamin Powers
A Phase I/II Open-Label Trial of CPI-613� devimistat plus Hydroxychloroquine to Evaluate Maximally Tolerated Dose MTD, Safety and Efficacy in Patients with Relapsed or Refractory Clear Cell Sarcoma CCS
Study Type: Treatment
Phase: I/II
NCTID: NCT04593758
Principal Investigator:
Benjamin Powers